About Helomics
Helomics is a company based in Pittsburgh (United States) founded in 1995 was acquired by Predictive Oncology in June 2018.. Helomics has raised $195.59 million across 9 funding rounds from investors including Predictive Oncology, Draper Triangle and HealthCare Royalty Partners. The company has 13 employees as of December 31, 2018. Helomics offers products and services including AI/ML Platform, 3D Tumor Models, and ChemoFx Testing. Helomics operates in a competitive market with competitors including Jazz Pharmaceuticals, Denali Therapeutics, C4 Therapeutics, Erasca and Revolution Medicines, among others.
- Headquarter Pittsburgh, United States
- Employees 13 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$195.59 M (USD)
in 9 rounds
-
Latest Funding Round
$3 M (USD), Series E
Apr 23, 2018
-
Investors
Predictive Oncology
& 11 more
-
Employee Count
13
as on Dec 31, 2018
-
Acquired by
Predictive Oncology
(Jun 28, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Helomics
Helomics offers a comprehensive portfolio of products and services, including AI/ML Platform, 3D Tumor Models, and ChemoFx Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform predicts drug responses using tumor samples and machine learning.
Models mimic patient responses for oncology drug development testing.
Service for tumor drug-response and genomic biomarker analysis.
Funding Insights of Helomics
Helomics has successfully raised a total of $195.59M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $3 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $3.0M
-
First Round
First Round
(13 Nov 2001)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series E - Helomics | Valuation |
investors |
|
| Jun, 2017 | Amount | Series E - Helomics | Valuation |
investors |
|
| Mar, 2017 | Amount | Series E - Helomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Helomics
Helomics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Predictive Oncology, Draper Triangle and HealthCare Royalty Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare royalty investments are focused on US and UK markets.
|
Founded Year | Domain | Location | |
|
Early-stage VC investments are made in US tech companies.
|
Founded Year | Domain | Location | |
|
US focused early-stage VC firm investing in tech & life sciences start-ups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Helomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Helomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Helomics Comparisons
Competitors of Helomics
Helomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Denali Therapeutics, C4 Therapeutics, Erasca and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Helomics
Frequently Asked Questions about Helomics
When was Helomics founded?
Helomics was founded in 1995 and raised its 1st funding round 6 years after it was founded.
Where is Helomics located?
Helomics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Is Helomics a funded company?
Helomics is a funded company, having raised a total of $195.59M across 9 funding rounds to date. The company's 1st funding round was a Series E of $1.98M, raised on Nov 13, 2001.
How many employees does Helomics have?
As of Dec 31, 2018, the latest employee count at Helomics is 13.
What does Helomics do?
Helomics was established in 1995 in Pittsburgh, United States, within the biotechnology sector focused on oncology. An AI-driven platform is operated to create targeted therapies for cancer patients. Proprietary technology and data pipelines are maintained to deliver services to pharmaceutical and diagnostic firms, supporting the advancement of precision medicine solutions in the region.
Who are the top competitors of Helomics?
Helomics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Helomics offer?
Helomics offers AI/ML Platform, 3D Tumor Models, and ChemoFx Testing.
Who are Helomics's investors?
Helomics has 12 investors. Key investors include Predictive Oncology, Draper Triangle, HealthCare Royalty Partners, Adams Capital Management, and Birchmere Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.